share_log

Why Bolt Biotherapeutics Shares Are Trading Lower By Around 34%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session

Why Bolt Biotherapeutics Shares Are Trading Lower By Around 34%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session

爲什麼Bolt Biotherapeutics的股價下跌了約34%?以下是週三午盤交易中其他股票的走勢
Benzinga ·  05/15 13:38
Shares of Bolt Biotherapeutics, Inc. (NASDAQ:BOLT) fell sharply during Wednesday's session after the company reported first-quarter financial results.
Bolt Biotherapeutics, Inc.(納斯達克股票代碼:BOLT)公佈第一季度財務業績後,該公司股價在週三的交易中大幅下跌。
Bolt Biotherapeutics posted a GAAP loss of 28 cents per share on sales of $5.30 million, according to data from Benzinga Pro.
根據Benzinga Pro的數據,Bolt Biotherapeutics公佈的GAAP每股虧損28美分,銷售額爲530萬美元。
Also, Guggenheim analyst Michael Schmidt downgraded Bolt Biotherapeutics from Buy to Neutral, while Stifel analyst Stephen Willey downgraded the stock from Buy to Hold and lowered the price target from $6 to $1.5.
此外,古根海姆分析師邁克爾·施密特將Bolt Biotherapeutics的評級從買入下調至中性,而Stifel分析師斯蒂芬·威利則將該股的評級從買入下調至持有,並將目標股價從6美元下調至1.5美元。
Bolt Biotherapeutics shares dipped 34.4% to $0.8652 on Wednesday.
週三,Bolt Biotherapeutics股價下跌34.4%,至0.8652美元。
Here are some other stocks moving in today's mid-day session.
以下是今天中午交易時段中其他一些走勢的股票。
Gainers
獲勝者
AERWINS Technologies Inc. (NASDAQ:AWIN) shares surged 201% to...
AERWINS ...
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論